U.S. Healthtech Stock News

IES Holdings (IESC) just delivered a strong one two punch, beating expectations on fourth quarter and full year results while announcing the Gulf Island Fabrication acquisition, and investors are now reassessing what this data center driven story is worth. See our latest analysis for IES Holdings. That backdrop helps explain why, even after a 3.69% one day share price pullback, IES Holdings still boasts a 26.17% one month share price return and a towering 1,527.16% three year total...

HNI stock has quietly swung this year, with shares down about 16% year to date but still up sharply over the past 3 years. That makes today’s valuation especially interesting. See our latest analysis for HNI. In the near term, HNI’s share price return has been choppy, with a modest bounce over the past month, but the three year total shareholder return of 68% still speaks to underlying confidence, even if momentum is cooling for now. If HNI’s mixed momentum has you rethinking where to find...

Chevron (CVX) just tightened its 2026 playbook by reaffirming $18 billion to $19 billion in capital spending and lifting its cost savings goal to $3 billion to $4 billion, effectively doubling down on efficiency and free cash flow. See our latest analysis for Chevron. Against that backdrop, Chevron’s share price has eased in recent months even as governance tweaks, Venezuela negotiations and the Hess integration dominate headlines. However, its five year total shareholder return of about 113%...

TeraWulf Inc. recently completed the mandatory conversion of its Series A Convertible Preferred Stock into common stock, simplifying its capital structure following director Michael C. Bucella’s purchase of 4,178 additional shares. This combination of balance sheet simplification and fresh insider investment is drawing attention as the company works through profitability challenges and elevated leverage. Next, we’ll examine how the preferred-to-common conversion could reshape TeraWulf’s...

If you are wondering whether Nova is still a smart buy after such a big run, you are not alone. This article is going to dig straight into what the current price really implies about its value. The stock has cooled slightly in the last week, down 2.7%. That comes after a 6.4% gain over 30 days and a 55.7% year-to-date climb, with 67.7% over 1 year and 345.6% over 5 years, which indicates investors have been steadily bidding up its future prospects. Recent attention on the semiconductor...

Campbell's (CPB) just delivered a tough first quarter, with lower sales and adjusted earnings rattling an already weak stock, and the swift wave of reduced analyst expectations has only sharpened investor focus on margins. See our latest analysis for Campbell's. At a share price of $28.74, Campbell's has seen its 30 day share price return fall 8.15% and its 1 year total shareholder return slump 30.15%, signaling fading momentum despite steady guidance and bond issuance to strengthen its...

Youdao (NYSE:DAO) has quietly turned in steady gains this year, and that kind of under the radar move often signals investors are starting to reassess the company’s long term learning-tech story. See our latest analysis for Youdao. At around $9.02 per share, Youdao’s year to date share price return of 26.51% and three year total shareholder return of 73.46% suggest investors are gradually warming to its improving growth profile, even if near term share price momentum has been choppy. If...

Tripadvisor (TRIP) has struggled to hold gains despite steady revenue and faster growing earnings, leaving the stock drifting after a weak past 3 months and a sharp slide over five years. See our latest analysis for Tripadvisor. Over the past year, Tripadvisor’s modest 1 year to date share price return of 1.2 percent contrasts with a stronger 1 year total shareholder return of 10.17 percent. This suggests dividends and reinvested returns have done more of the heavy lifting than recent price...

Why FactSet Is Back on Investors Radar FactSet Research Systems (FDS) has quietly outperformed over the past month, even as its longer term returns remain under pressure. That mix of short term momentum and deeper drawdown is exactly what makes the stock interesting now. See our latest analysis for FactSet Research Systems. That recent 1 month share price return of 6.78 percent comes after a much tougher stretch, with the year to date share price return down 38.62 percent and the 1 year total...

Rockwell Automation (ROK) just doubled down on its digital manufacturing ambitions, rolling out an elastic, cloud native MES platform that tightly links factory floor systems with IT, and analysts are clearly taking notice. See our latest analysis for Rockwell Automation. The stock is reflecting that optimism, with a 30 day share price return of 7.44 percent and a year to date share price gain of 44.25 percent. The five year total shareholder return of 78.04 percent shows that momentum has...

Earlier this month, AngloGold Ashanti plc presented at the Resourcing Tomorrow Conference in London, where senior executives outlined operational developments and community relations initiatives following the Centamin and Sukari mine acquisition. The company’s confirmation of a large year-on-year production increase, underpinned by the newly added long-life Sukari asset, highlights a meaningful shift in its portfolio scale and resilience. We’ll now examine how the Sukari-driven production...

Cavco Industries (CVCO) has quietly built meaningful long term returns, with the stock up about 36% year to date and roughly 161% over the past 3 years, well ahead of the broader market. See our latest analysis for Cavco Industries. The latest share price of $597.03 and a steady 30 day share price return of 7.00% suggest momentum is still building, while the 3 year total shareholder return of 161.42% points to a long running rerating story based on improving growth expectations and lower...

CACI International Inc. recently announced two multi-year U.S. defense task orders worth up to US$145 million with the Navy’s Portsmouth Naval Shipyard and up to US$79 million with the Army’s C5ISR Center, extending its role in undersea engineering, electronic warfare, and spectrum-focused support. Together with a new Second Amended and Restated Credit Agreement providing a US$1.25 billion term loan and US$2.00 billion revolving facility maturing in 2030, these awards highlight CACI’s deep...

Recently, Gevo reported a strong Q3 marked by record carbon credit sales, expanding sustainable jet fuel partnerships, and a new US$26.00 million collaboration with BioRecro to enhance its carbon management platform, while its CFO Oluwagbemileke Yusuf Agiri sold a significant number of shares. This mix of operational progress in renewable fuels and carbon management alongside insider selling offers investors a nuanced view of Gevo’s current trajectory. We’ll now examine how the BioRecro...

WSFS Financial (WSFS) just wrapped up a $200 million fixed income deal that reshapes its balance sheet by retiring older 2030 notes and freeing up capital, a meaningful signal for both bondholders and equity investors. See our latest analysis for WSFS Financial. The bond refinancing fits into a steady grind higher, with an 11.03% year to date share price return and a 47.53% five year total shareholder return suggesting momentum is gradually building rather than fading. If this kind of balance...

VEON (NasdaqCM:VEON) just unlocked a new growth lever in Bangladesh, with its Banglalink unit cleared by Bangladesh Bank to operate as a payment service provider, opening fresh opportunities in digital financial services. See our latest analysis for VEON. The Banglalink approval adds to a string of positive catalysts, from Kyivstar’s role in building Ukraine’s national LLM to fresh index inclusions, and investors have noticed, with a roughly 20% year to date share price return and a powerful...

The Bank of N.T. Butterfield & Son Limited recently authorized a new share repurchase program, allowing the buyback of up to 3,000,000 ordinary shares for US$140 million through December 31, 2026. This sizable capital return plan, which replaces the current buyback program, highlights management’s confidence in the bank’s balance sheet strength and capital flexibility. We’ll now examine how this newly authorized US$140 million share repurchase program could reshape Butterfield’s investment...

Corpay (CPAY) has quietly turned into a long-term compounder, even as the stock slipped around 11% over the past year and remains down year-to-date. That disconnect is where things get interesting for investors. See our latest analysis for Corpay. Despite the softer year to date share price return of around 7% and a one year total shareholder return of roughly 11% in the red, Corpay’s recent 30 day share price gain above 13% hints that momentum may be quietly turning back in its favor as...

Sea (NYSE:SE) has quietly slipped about 11% over the past month and roughly 34% in the past 3 months, even as revenue and net income continue to grow at a double digit clip. See our latest analysis for Sea. That recent 30 day share price slide sits against a still positive year to date share price return, along with a three year total shareholder return above 130%, suggesting long term believers have been rewarded even as short term momentum cools. If Sea's pullback has you scanning for the...

If you have been wondering whether DENTSPLY SIRONA is a bargain or a value trap at around $11.57, you are not alone. This is exactly the kind of stock where a closer valuation check can really change your view. The share price has bounced 2.8% over the last week and 10.0% over the past month, yet it is still down a steep 38.3% year to date and 38.8% over the last year, after much heavier 3-year and 5-year declines. Recent headlines have focused on DENTSPLY SIRONA's strategic reshaping of its...

In early December 2025, GENinCode announced a collaboration with Thermo Fisher Scientific to manufacture, sell and distribute the CARDIO inCode-Score polygenic risk test for coronary heart disease prediction across the US and EMEA, leveraging Thermo Fisher’s QuantStudio 5 Dx Real-Time PCR System and global footprint. Alongside this, Thermo Fisher’s expansion of bioprocessing design centers in Asia reinforces its role as a global partner in both advanced diagnostics and biomanufacturing...

If you are wondering whether Peloton Interactive at around $6.54 is a beaten down bargain or a value trap, you are not alone. That is exactly what we are going to unpack here. Despite a brutal longer term ride, with the stock down about 95.3% over 5 years and 31.7% over the last year, it has shown some near term resilience. It edged up 1.9% in the past week, even after a 12.6% slide over the last month and a 25.9% drop year to date. Recent headlines have focused on Peloton's ongoing...

TD SYNNEX (SNX) has quietly outperformed many tech peers this year, with the stock up roughly 34% year to date. That move invites a closer look at whether the current valuation still leaves upside. See our latest analysis for TD SYNNEX. The latest leg higher, including a roughly 3.3% 1 month share price return and a 33.6% year to date share price gain to about $155.66, adds to an already solid three year total shareholder return of just over 70%. This suggests momentum is still broadly...

AMREP (AXR) has just posted Q2 2026 results, with revenue of about $9.4 million, basic EPS of roughly $0.22, and net income of around $1.2 million setting the tone for the quarter. The company has seen revenue move from $11.9 million and EPS of about $0.76 in Q2 2025 to $9.4 million and $0.22 in Q2 2026. Trailing 12 month revenue sits near $45.9 million and EPS around $1.97, giving investors plenty to consider on the growth and earnings front as they weigh the latest margins picture. See our...